PROCESS FOR PRODUCING XANTHINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME AS ACTIVE INGREDIENT, AGAINST DISORDERS OF CEREBRATION

摘要

The use of xanthine derivatives of the formula I and of their physiologically tolerated salts, where R<1> is oxoalkyl, hydroxyalkyl or alkyl, R<2> is hydrogen or alkyl and R<3> is hydrogen, alkyl, oxoalkyl or an alkyl which has up to 6 carbon atoms and whose carbon chain is interrupted by an oxygen atom, for the manufacture of medicaments for the treatment of disorders which may occur after craniocerebral trauma, is described.